SEC Company Response from Viewbix Inc. (VBIX) (CIK 0000797542) (QXL) — Jan 15, 2016
Viewbix Inc. (VBIX) (CIK 0000797542)
Date: Jan. 15, 2016 · CIK: 0000797542 · Accession: 0001295345-16-000414
AI Filing Summary & Sentiment
File numbers found in text: 333-206105
Letter
Re: Emerald Medical Applications Corp.
Emerald Medical Applications Corp.
7 Imber Street Petach Tikva, 4951141 Israel
January 15, 2016
US Securities and Exchange Commission
Division of Corporation Finance
Washington, DC 20549
Attention: Mara L. Ransom, Assistant Director
Registration Statement on Form S-1
Commission File No. 333-206105
Request for Acceleration
Ladies and Gentlemen:
On behalf of Emerald Medical Applications Corp. this is to request that the above-referenced registration statement be declared effective by the Commission on January 20, 2016 at 9:30 a.m. EST or as soon thereafter as reasonably practicable.
The Company acknowledges that since the Company and its management are in possession of all facts relating to a Company's disclosure, the Company and its management are responsible for the accuracy and adequacy of the disclosures they have made.
The Company acknowledges that:
- should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
- the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
- the company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Respectfully
submitted,
/s/: Lior Wayn
Lior Wayn, Chief Executive Officer
Show Raw Text
CORRESP 1 filename1.htm Emerald Medical Applications Corp. 7 Imber Street Petach Tikva, 4951141 Israel January 15, 2016 US Securities and Exchange Commission Division of Corporation Finance Washington, DC 20549 Attention: Mara L. Ransom, Assistant Director Re: Emerald Medical Applications Corp. Registration Statement on Form S-1 Commission File No. 333-206105 Request for Acceleration Ladies and Gentlemen: On behalf of Emerald Medical Applications Corp. this is to request that the above-referenced registration statement be declared effective by the Commission on January 20, 2016 at 9:30 a.m. EST or as soon thereafter as reasonably practicable. The Company acknowledges that since the Company and its management are in possession of all facts relating to a Company's disclosure, the Company and its management are responsible for the accuracy and adequacy of the disclosures they have made. The Company acknowledges that: - should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; - the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and - the company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Respectfully submitted, /s/: Lior Wayn Lior Wayn, Chief Executive Officer